CGTX
Cognition Therapeutics Inc
NASDAQ: CGTX · HEALTHCARE · BIOTECHNOLOGY
$1.26
+6.78% today
Updated 2026-04-30
Market cap
$114.37M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.32
Dividend yield
—
52W range
$0 – $4
Volume
1.2M
Cognition Therapeutics Inc (CGTX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-3.10M | $-3.43M | $-3.63M | $-18.53M | $-16.02M | $-28.47M | $-24.59M |
| Capital expenditures | $144000.00 | $10000.00 | $27000.00 | $171000.00 | $147000.00 | $4000.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $361.00 | $475000.00 | $5.18M | $3.57M | $4.35M | $3.75M | $2.09M |
| Free cash flow | $-3.24M | $-3.44M | $-3.66M | $-18.70M | $-16.16M | $-28.48M | $-24.59M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-13.16M | — | — | — |